Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2014 1
2015 2
2017 1
2018 3
2019 2
2020 4
2021 6
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Unloading, ablation, bridging and transplant: different indications and treatments using the Impella 5.5 as longer-term circulatory support in one patient-an interdisciplinary case report.
Volgmann C, Barten MJ, Al Assar Y, Grahn H, Metzner A, Söffker G, Schulte-Uentrop L, Magnussen C, Kirchhof P, Kluge S, Doll S, Doll N, Reichenspurner H, Bernhardt AM. Volgmann C, et al. Among authors: soffker g. Eur Heart J Case Rep. 2023 Jul 3;7(7):ytad293. doi: 10.1093/ehjcr/ytad293. eCollection 2023 Jul. Eur Heart J Case Rep. 2023. PMID: 37457054 Free PMC article.
Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial.
Wolfrum S, Roedl K, Hanebutte A, Pfeifer R, Kurowski V, Riessen R, Daubmann A, Braune S, Söffker G, Bibiza-Freiwald E, Wegscheider K, Schunkert H, Thiele H, Kluge S; Hypothermia After In-Hospital Cardiac Arrest Study Group. Wolfrum S, et al. Among authors: soffker g. Circulation. 2022 Nov;146(18):1357-1366. doi: 10.1161/CIRCULATIONAHA.122.060106. Epub 2022 Sep 28. Circulation. 2022. PMID: 36168956 Clinical Trial.
Clinical characteristics, causes and predictors of outcomes in patients with in-hospital cardiac arrest: results from the SURVIVE-ARREST study.
Hannen LEM, Toprak B, Weimann J, Mahmoodi B, Fluschnik N, Schrage B, Roedl K, Söffker G, Kluge S, Issleib M, Blankenberg S, Kirchhof P, Clemmensen P, Sinning C, Zengin-Sahm E, Becher PM. Hannen LEM, et al. Among authors: soffker g. Clin Res Cardiol. 2023 Feb;112(2):258-269. doi: 10.1007/s00392-022-02084-1. Epub 2022 Aug 17. Clin Res Cardiol. 2023. PMID: 35978110 Free PMC article.
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial.
Karakas M, Akin I, Burdelski C, Clemmensen P, Grahn H, Jarczak D, Keßler M, Kirchhof P, Landmesser U, Lezius S, Lindner D, Mebazaa A, Nierhaus A, Ocak A, Rottbauer W, Sinning C, Skurk C, Söffker G, Westermann D, Zapf A, Zengin E, Zeller T, Kluge S. Karakas M, et al. Among authors: soffker g. Lancet Respir Med. 2022 Mar;10(3):247-254. doi: 10.1016/S2213-2600(21)00439-2. Epub 2021 Dec 8. Lancet Respir Med. 2022. PMID: 34895483 Clinical Trial.
26 results